Skip to Main Content (Press Enter)

Logo UNIMI
  • ×
  • Home
  • People
  • Projects
  • Fields
  • Units
  • Outputs
  • Third Mission

Expertise & Skills
Logo UNIMI

|

Expertise & Skills

unimi.it
  • ×
  • Home
  • People
  • Projects
  • Fields
  • Units
  • Outputs
  • Third Mission
  1. Outputs

Safety of statins: focus on clinical pharmacokinetics and drug interactions

Academic Article
Publication Date:
2004
Citation:
Safety of statins: focus on clinical pharmacokinetics and drug interactions / S. Bellosta, R. Paoletti, A. Corsini. - In: CIRCULATION. - ISSN 0009-7322. - 109:23 (Suppl. 1)(2004 Jun 15), pp. III-50-III-57.
abstract:
Statin monotherapy is generally well tolerated, with a low frequency of adverse events. The most important adverse effects associated with statins are myopathy and an asymptomatic increase in hepatic transaminases, both of which occur infrequently. Because statins are prescribed on a long-term basis, however, possible interactions with other drugs deserve particular attention, as many patients will typically receive pharmacological therapy for concomitant conditions during the course of statin treatment. This review summarizes the pharmacokinetic properties of statins and emphasizes their clinically relevant drug interactions.
IRIS type:
01 - Articolo su periodico
Keywords:
Drug interactions; Fibrates; Rhabdomyolysis; Safety; Statins
List of contributors:
S. Bellosta, R. Paoletti, A. Corsini
Authors of the University:
BELLOSTA STEFANO ( author )
CORSINI ALBERTO ( author )
Link to information sheet:
https://air.unimi.it/handle/2434/143653
Full Text:
https://air.unimi.it/retrieve/handle/2434/143653/246089/2004%20Circulation%20Safety%20of%20statins.pdf
  • Research Areas

Research Areas

Concepts


Settore BIO/14 - Farmacologia
  • Guide
  • Help
  • Accessibility
  • Privacy
  • Use of cookies
  • Legal notices

Powered by VIVO | Designed by Cineca | 26.5.1.0